In conclusion, our study demonstrates that cisplatin-resistant ovarian cancer cell lines upregulate HSP27 and FAO to deplete cisplatin-induced ROS to attenuate the cytotoxic effect of cisplatin. The gene discussed is HSPB1; the disease is ovarian cancer.